Prompt admission to intensive care is associated with improved survival in patients with severe sepsis and/or septic shock

The Journal of International Medical Research
Qiang LiZhongheng Zhang

Abstract

Objective To investigate the association between time from hospital admission to intensive care unit (ICU) admission (door to ICU time) and hospital mortality in patients with sepsis. Methods This retrospective observational study included routinely collected healthcare data from patients with sepsis. The primary endpoint was hospital mortality, defined as the survival status at hospital discharge. Door to ICU time was calculated and included in a multivariable model to investigate its association with mortality. Results Data from 13 115 patients were included for analyses, comprising 10 309 survivors and 2 806 non-survivors. Door to ICU time was significantly longer for non-survivors than survivors (median, 43.0 h [interquartile range, 12.4, 91.3] versus 26.7 h [7.0, 74.2]). In the multivariable regression model, door to ICU time remained significantly associated with mortality (odds ratio [OR] 1.11, 95% confidence interval [CI] 1.006, 1.017) and there was a significant interaction between age and door to ICU time (OR 0.99, 95% CI 0.99, 1.00). Conclusion A shorter time from hospital door to ICU admission was shown to be independently associated with reduced hospital mortality in patients with severe sepsis and/or septic shock.

References

Jan 17, 2002·The New England Journal of Medicine·E RiversUNKNOWN Early Goal-Directed Therapy Collaborative Group
Apr 19, 2007·Critical Care Medicine·Donald B ChalfinUNKNOWN DELAY-ED study group
Dec 26, 2007·Critical Care Medicine·R Phillip DellingerUNKNOWN World Federation of Societies of Intensive and Critical Care Medicine
Aug 22, 2009·Chest·Anand KumarUNKNOWN Cooperative Antimicrobial Therapy of Septic Shock Database Research Group
Feb 27, 2010·The European Respiratory Journal·J PhuaT K Lim
May 4, 2012·Journal of Internal Medicine·E BurriC Mueller
Jan 31, 2013·Intensive Care Medicine·R P DellingerUNKNOWN Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup
Oct 2, 2014·The New England Journal of Medicine·Sandra L PeakePatricia Williams
Feb 24, 2016·JAMA : the Journal of the American Medical Association·Mervyn SingerDerek C Angus
Apr 2, 2016·Critical Care Medicine·Jesús VillarUNKNOWN Stratification and Outcome of Acute Respiratory Distress Syndrome (STANDARDS) Network
Apr 6, 2016·Annals of Translational Medicine·Zhongheng Zhang
May 25, 2016·Scientific Data·Alistair E W JohnsonRoger G Mark
Jun 14, 2016·Annals of Translational Medicine·Zhongheng Zhang
Aug 25, 2016·Medicina intensiva·R García-GigorroJ C Montejo González
Sep 27, 2016·Annals of Translational Medicine·Petros KopteridesSachin Yende
Oct 1, 2016·Intensive Care Medicine·UNKNOWN SepNet Critical Care Trials Group
Nov 22, 2016·Annals of Translational Medicine·Tanner JohannsDaniel Morgensztern
Jan 20, 2017·Intensive Care Medicine·Andrew RhodesR Phillip Dellinger
Mar 10, 2017·Journal of Thoracic Disease·Zhongheng ZhangPietro Caironi
Jan 5, 2018·Annals of Translational Medicine·Zhongheng ZhangPablo Cardinal-Fernández

❮ Previous
Next ❯

Citations

Oct 22, 2021·Critical Care Explorations·Scott C BrakenridgeLyle L Moldawer

❮ Previous
Next ❯

Software Mentioned

Compare Baseline Characteristics Between Groups ( CBCgrps )
Regression Modelling Strategies ( rms )
R

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.